New Jersey A 3406: Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.

Status: Introduced, Referred to Assembly Financial Institutions and Insurance Committee (as of 2026-01-13)

State: New Jersey · Session: 222 · Bill: A 3406

Sponsors: Bailey, David, Jr., Simmons, Heather

View New Jersey A 3406 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.